DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+8.8%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$285M
AUM Growth
+$285M
(+14%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
67.96%
Holding
106
New
7
Increased
9
Reduced
23
Closed
14
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$2.39M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
$1.6M |
| 3 |
Lexicon Pharmaceuticals
LXRX
|
$785K |
| 4 |
ZimVie
ZIMV
|
$567K |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$514K |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$7.16M |
| 2 |
Viking Therapeutics
VKTX
|
$2.34M |
| 3 |
LK
Luckin Coffee Inc. American Depositary Shares
LK
|
$2.11M |
| 4 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
$1.25M |
| 5 |
Evolus
EOLS
|
$828K |
Sector Composition
| 1 | Healthcare | 30.44% |
| 2 | Materials | 27.67% |
| 3 | Financials | 18.27% |
| 4 | Communication Services | 6.88% |
| 5 | Technology | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
26
DELISTED
Enstar Group
ESGR
| $2.41M | 0.85% |
7,500
| – | – |
|
|
27
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.39M | 0.84% |
+34,000
| New | +$2.39M |
|
28
Protagonist Therapeutics
PTGX
$3.67B
| $2.36M | 0.83% |
52,368
| – | – |
|
29
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.35M | 0.83% |
122,144
+18,318
| +18% | +$353K |
|
30
Digimarc
DMRC
$188M
| $2.25M | 0.79% |
83,557
| – | – |
|
|
MREO
31
Mereo BioPharma
MREO
$272M
| $1.36M | 0.48% |
331,000
+95,000
| +40% | +$390K |
|
32
Ryman Hospitality Properties
RHP
$6.22B
| $1.29M | 0.45% |
12,000
| – | – |
|
33
SPDR S&P Biotech ETF
XBI
$5.07B
| $988K | 0.35% |
10,000
-4,000
| -29% | -$395K |
|
|
34
Evolus
EOLS
$494M
| $933K | 0.33% |
57,570
-51,112
| -47% | -$828K |
|
35
Vertex Pharmaceuticals
VRTX
$100B
| $930K | 0.33% |
2,000
-1,000
| -33% | -$465K |
|
36
DuPont de Nemours
DD
$32.2B
| $885K | 0.31% |
9,930
| – | – |
|
37
Kimberly-Clark
KMB
$42.8B
| $854K | 0.3% |
6,000
| – | – |
|
38
Ironwood Pharmaceuticals
IRWD
$214M
| $853K | 0.3% |
207,033
-162,967
| -44% | -$671K |
|
39
Xenon Pharmaceuticals
XENE
$2.98B
| $821K | 0.29% |
20,866
| – | – |
|
|
40
Lexicon Pharmaceuticals
LXRX
$400M
| $785K | 0.28% |
+500,000
| New | +$785K |
|
41
Roivant Sciences
ROIV
$8.15B
| $711K | 0.25% |
61,583
-1,417
| -2% | -$16.4K |
|
42
Microsoft
MSFT
$3.77T
| $688K | 0.24% |
1,600
| – | – |
|
43
Corteva
CTVA
$50.4B
| $680K | 0.24% |
11,563
| – | – |
|
44
Mondelez International
MDLZ
$79.5B
| $663K | 0.23% |
9,000
-5,000
| -36% | -$368K |
|
|
45
ZimVie
ZIMV
$532M
| $567K | 0.2% |
+35,750
| New | +$567K |
|
46
Amazon
AMZN
$2.44T
| $559K | 0.2% |
300
| – | – |
|
47
Canadian Natural Resources
CNQ
$65.9B
| $558K | 0.2% |
16,800
| – | – |
|
48
Xoma
XOMA
$392M
| $522K | 0.18% |
19,722
| – | – |
|
49
Panagram AAA CLO ETF
CLOX
$220M
| $500K | 0.18% |
19,572
| – | – |
|
50
Alphabet (Google) Class A
GOOGL
$2.57T
| $497K | 0.17% |
300
| – | – |
|